Cart
sales@molnova.com
TDI-011536
CAS No. 2687970-96-1
TDI-011536( —— )
Catalog No. M35339 CAS No. 2687970-96-1
TDI-011536, a potent Lats kinase inhibitor, disrupts Hippo-Yap signaling and promotes the proliferation of lesioned heart muscle cells. This compound is valuable for research in organ conservation and regeneration.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 48 | In Stock |
|
| 10MG | 76 | In Stock |
|
| 25MG | 163 | In Stock |
|
| 50MG | 259 | In Stock |
|
| 100MG | 423 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTDI-011536
-
NoteResearch use only, not for human use.
-
Brief DescriptionTDI-011536, a potent Lats kinase inhibitor, disrupts Hippo-Yap signaling and promotes the proliferation of lesioned heart muscle cells. This compound is valuable for research in organ conservation and regeneration.
-
DescriptionTDI-011536 is a potent Lats kinase inhibitor, interrupts Hippo-Yap signaling and initiates the proliferation of lesioned heartmuscle cells. TDI-011536 can be used in studies of organ conservation and regeneration.
-
In VitroCell Proliferation Assay Cell Line:human retinal organoids Concentration:3 μM Incubation Time:24 h, 5 days Result:Supressed Yap phosphorylation and promoted Müller glia proliferation.
-
In VivoAnimal Model:Living mice (immunoblot analysis of the heart, liver, and skin immediately after injection).Dosage:200 mg/kg Administration:Intraperitoneal injections; once.Result:Reduced the amount of pYap for at least 4 h after injection in all three organs and the levels returned to control values within a day.Animal Model:Male 8-week-old mice (cryolesion model).Dosage:100 mg/kg Administration:Intraperitoneal injections; once daily for 2 or 3 days.Result:Promoted cardiomyocytes proliferation.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2687970-96-1
-
Formula Weight364.42
-
Molecular FormulaC19H16N4O2S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (343.01 mM; Ultrasonic )
-
SMILESOCc1cs\c(=N/C(=O)c2c[nH]c3ncccc23)n1Cc1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kastan NR, et al. Development of an improved inhibitor of Lats kinases to promote regeneration of mammalian organs. Proc Natl Acad Sci U S A. 2022 Jul 12;119(28):e2206113119. ?
molnova catalog
related products
-
Leritrelvir
Leritrelvir (RAY1216) is a potent orally active inhibitor of the SARS-CoV-2 main protease, exhibiting a slow-tight binding mechanism with an inhibition constant (Ki) of 8.6 nM .
-
Lithospermate B
Lithospermate B is a natural product activates eNOS and ameliorates endothelial dysfunction in diabetes by enhancing vasodilation in addition to reducing oxidative stress, it can protecte cardiomyocytes from ischemic injury through specific inhibition of TAB1-p38 apoptosis signaling.
-
Hexadecanedioic acid
Hexadecanedioic acid is a common saturated fatty acid found in animals plants and microorganisms. It has antitumor activity.
